Argus Research analyst Angus Kelleher-Ferguson downgrades Vornado Realty (NYSE:VNO) from Buy to Hold.
Gilead’s Trodelvy Shows Improved Overall Survival In Pretreated Breast Cancer Settings
Gilead Sciences Inc (NASDAQ:GILD) announced the overall survival (OS) results from the Phase 3 TROPiCS-02 study of Trodelvy (sacituzumab govitecan-hziy) versus…